High-throughput quantification of the anti-leukemia drug STI571 (Gleevec) and its main metabolite (CGP 74588) in human plasma using liquid chromatography-tandem mass spectrometry (Q33424938)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	High-throughput quantification of the anti-leukemia drug STI571 (Gleevec) and its main metabolite (CGP 74588) in human plasma using liquid chromatography-tandem mass spectrometry	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

26 July 2017

High-throughput quantification of the anti-leukemia drug STI571 (Gleevec) and its main metabolite (CGP 74588) in human plasma using liquid chromatography-tandem mass spectrometry (English)

1 reference

Europe PubMed Central

26 July 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

liquid chromatography-tandem mass spectrometry

1 reference

based on heuristic

inferred from title

author name string

Bakhtiar R

1

1 reference

Europe PubMed Central

26 July 2017

Lohne J

2

1 reference

Europe PubMed Central

26 July 2017

Ramos L

3

1 reference

Europe PubMed Central

26 July 2017

Khemani L

4

1 reference

Europe PubMed Central

26 July 2017

Hayes M

5

1 reference

Europe PubMed Central

26 July 2017

Tse F

6

1 reference

Europe PubMed Central

26 July 2017

publication date

1 March 2002

1 reference

Europe PubMed Central

26 July 2017

Journal of Chromatography B Analytical Technologies in the Biomedical and Life Sciences

1 reference

Europe PubMed Central

26 July 2017

768

1 reference

Europe PubMed Central

26 July 2017

325-340

1 reference

Europe PubMed Central

26 July 2017

2

1 reference

Europe PubMed Central

26 July 2017

describes a project that uses

liquid chromatography-tandem mass spectrometry

1 reference

based on heuristic

inferred from title

Status of bcr-abl tyrosine kinase inhibitors in chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2801%2900611-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Tyrosine-kinase inhibition in treatment of chronic myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2801%2900611-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic myeloid leukaemia. STI 571 magnifies the therapeutic dilemma

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2801%2900611-0

7 January 2021

based on heuristic

inferred from DOI database lookup

STI571: targeting BCR-ABL as therapy for CML.

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2801%2900611-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2801%2900611-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2801%2900611-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2801%2900611-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Lessons learned from the development of an abl tyrosine kinase inhibitor for chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2801%2900611-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Oncogenic kinase signalling

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2801%2900611-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Protein tyrosine kinase structure and function

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2801%2900611-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of tumor angiogenesis by synthetic receptor tyrosine kinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2801%2900611-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular abnormalities in chronic myeloid leukemia: deregulation of cell growth and apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2801%2900611-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Current trends in the management of chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2801%2900611-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Trial of IFN or STI571 before proceeding to allografting for CML?

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2801%2900611-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Structural mechanism for STI-571 inhibition of abelson tyrosine kinase

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2801%2900611-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Atmospheric pressure ionization LC/MS/MS techniques for drug disposition studies

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2801%2900611-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Mass spectrometry innovations in drug discovery and development

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2801%2900611-0

7 January 2021

based on heuristic

inferred from DOI database lookup

LC/MS applications in drug development

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2801%2900611-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Separations combined with mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2801%2900611-0

7 January 2021

based on heuristic

inferred from DOI database lookup

High-throughput high-performance liquid chromatography/mass spectrometry for modern drug discovery

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2801%2900611-0

7 January 2021

based on heuristic

inferred from DOI database lookup

High-throughput approaches to the quantitative analysis of ketoconazole, a potent inhibitor of cytochrome P450 3A4, in human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2801%2900611-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Automated protein precipitation by filtration in the 96-well format

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2801%2900611-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The development of a staggered parallel separation liquid chromatography/tandem mass spectrometry system with on-line extraction for high-throughout screening of drug candidates in biological fluids

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2801%2900611-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Integrated sample collection and handling for drug discovery bioanalysis

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2801%2900611-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A four-column parallel chromatography system for isocratic or gradient LC/MS analyses

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2801%2900611-0

7 January 2021

based on heuristic

inferred from DOI database lookup

High-throughput cytochrome P450 (CYP) inhibition screening via a cassette probe-dosing strategy. VI. Simultaneous evaluation of inhibition potential of drugs on human hepatic isozymes CYP2A6, 3A4, 2C9, 2D6 and 2E1.

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2801%2900611-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Higher throughput bioanalysis by automation of a protein precipitation assay using a 96-well format with detection by LC-MS/MS

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2801%2900611-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of manual protein precipitation (PPT) versus a new small volume PPT 96-well filter plate to decrease sample preparation time

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2801%2900611-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Matrix effect in quantitative LC/MS/MS analyses of biological fluids: a method for determination of finasteride in human plasma at picogram per milliliter concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2801%2900611-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantitation of SR 27417 in human plasma using electrospray liquid chromatography-tandem mass spectrometry: A study of ion suppression

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2801%2900611-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The effects of sample preparation methods on the variability of the electrospray ionization response for model drug compounds

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2801%2900611-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Targeting the BCR-ABL tyrosine kinase in chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2801%2900611-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1570-0232(01)00611-0

1 reference

Europe PubMed Central

26 July 2017

1 reference

Europe PubMed Central

26 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33424938&oldid=2144560738"